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Disrupted metal homeostasis is a consistent feature of neurodegenerative disease in
humans and is recapitulated in mouse models of Alzheimer’s disease, Parkinson’s disease,
amyotrophic lateral sclerosis (ALS) and neuronal ceriod lipofuscinosis.While the deﬁnitive
pathogenesis of neurodegenerative disease in humans remains to be fully elucidated,
disease-like symptoms in the mouse models are all driven by the presence or over-
expression of a putative pathogenic protein, indicating an in vivo relationship between
expression of these proteins, disrupted metal homeostasis and the symptoms of neuronal
failure. Recently it was established that mutant TAR DNA binding protein-43 (TDP-
43) is associated with the development of frontotemporal lobar degeneration and ALS.
Subsequent development of transgenic mice that express human TDP-43 carrying the
disease-causing A315T mutation has provided new opportunity to study the underlying
mechanisms of TDP-43-related neurodegenerative disease. We assessed the cognitive
and locomotive phenotype of TDP-43A315T mice and their wild-type littermates and also
assessed bulk metal content of brain and spinal cord tissues. Metal levels in the brain
were not affected by the expression of mutant TDP-43, but zinc, copper, and manganese
levels were all increased in the spinal cords of TDP-43A315T mice when compared to wild-
type littermates. Performance of the TDP-43A315T mice in the Y-maze test for cognitive
function was not signiﬁcantly different to wild-type mice. By contrast, performance of
the TDP-43A315T in the rotarod test for locomotive function was consistently worse than
wild-type mice. These preliminary in vivo data are the ﬁrst to show that expression of a
disease-causing form ofTDP-43 is sufﬁcient to disrupt metal ion homeostasis in the central
nervous system. Disrupted metal ion homeostasis in the spinal cord but not the brain may
explain why theTDP-43A315T mice show symptoms of locomotive decline and not cognitive
decline.
Keywords: amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration (FTLD), TAR DNA binding
protein-43 (TDP-43), copper (Cu), zinc (Zn), manganese (Mn), neurodegenerative disease
INTRODUCTION
Metals such as iron, copper and zinc are needed for normal cell
function and alterations to the bio-availability of these metals can
therefore have devastating consequences on the survival and func-
tionality of cells in all parts of the body. This is particularly true for
functionality of the central nervous system (CNS) because metal
ions are also required for normal synaptic function (Tamano and
Takeda, 2011). Underscoring the signiﬁcance of maintainingmetal
homeostasis in the CNS, disrupted metal homeostasis is evident
in many neurodegenerative diseases including Alzheimer’s disease
(AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis
(ALS). In AD, iron, copper, and zinc accumulate within amyloid
plaques (Connor et al., 1992; Lovell et al., 1998), in PD iron is
increased within the substantia nigra (Soﬁc et al., 1988), and in
ALS copper, zinc, manganese, and several other metals are all
increased in the cerebrospinal ﬂuid (Roos et al., 2013).
In addition to human tissue affected by neurodegenerative dis-
ease, animal models of these diseases also recapitulate elements
of metal dyshomeostasis; AD model mice that over-express the
amyloid-β precursor protein have decreased levels of copper and
zinc in the brain relative to wild-type controls (Maynard et al.,
2002) copper and iron are altered in the brains of PD model mice
(Matusch et al., 2010; Ayton et al., 2013) and zinc and copper
levels are altered in mutant SOD1 mouse models of ALS (Kiaei
et al., 2004; Tokuda et al., 2013). The presence of disrupted metal
homeostasis in animalmodels of neurodegenerative disease as well
as the human condition has encouraged development of thera-
peutic strategies that aim to correct this imbalance (Badrick and
Jones, 2011; Crouch and Barnham, 2012). However, conﬁrming
whether the loss of metal homeostasis in neurodegenerative dis-
ease represents a cause of the disease or a consequence of neuronal
dysfunction still requires further investigation.
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Frontotemporal lobar degeneration (FTLD) is a collective term
for neurodegenerative diseases that involve degeneration of the
frontal and temporal lobes of the brain (Pickering-Brown, 2010).
It can affect individuals from the age of 40, and in the aged
population, is one of the most common causes of dementia
(Knopman et al., 2004). There are three main sub-types of FTLD
based on their histology; dementia lacking distinct histology,
FTLD with tau-positive inclusions, and FTLD with tau-negative
ubiquitin-positive inclusions (FTLD-U). In 2006 it was established
that cytoplasmic inclusions present in the brains of people with
FTLD-U and in the spinal cords of people with ALS contained
aggregates of the TAR DNA binding protein-43 (TDP-43) (Neu-
mann et al., 2006). This provided the ﬁrst molecular evidence
to explain the comorbidity that is common to ALS and FTLD
(Lomen-Hoerth et al., 2002) and also led several groups to pro-
pose that ALS and FTLD-U represent two ends of a spectrum
of TDP-43-mediated neurodegenerative diseases that can collec-
tively be referred to as TDP-43 proteinopathies (Liscic et al., 2008;
Chen-Plotkin et al., 2010).
It is currently unclear whether disrupted metal homeostasis is
present in TDP-43 proteinopathies. In vitro studies have impli-
cated a role for metals in the aggregation of endogenous TDP-43
(Caragounis et al., 2010), and metal-based therapeutic strategies
have the potential to prevent aberrant TDP-43metabolism (Parker
et al., 2012); however, there is a current paucity of in vivo data. This
study utilizes the recently developedTDP-43A315T mousemodel of
FTLD/ALS (Wegorzewska et al., 2009) to assess whether the pres-
ence of a pathogenic formof TDP-43 affectsmetal ion homeostasis
in vivo, and if present, to assess whether altered metal homeostasis
may be associated with the symptoms of neuronal decline in an
animal model of TDP-43 proteinopathy.
MATERIALS AND METHODS
MATERIALS
Rabbit antibody to TDP-43 was purchased from Proteintech
(USA); rabbit antibodies to FLAG, histone H3, and GAPDH
were obtained from Cell Signaling (Australia). All other chemicals
were purchased from Sigma Aldrich (Australia) unless otherwise
stated.
ANIMALS
TDP-43A315T mice were purchased from The Jackson Laboratory
Repository (Stock no. 010700; Bar Harbor,ME,USA). This mouse
model was generated using themouse prion promoter and a cDNA
encoding human TARDBP with an A315T mutation and contain-
ing an N-terminal FLAG-tag (Wegorzewska et al., 2009). A colony
of TDP-43A315T mice was maintained by breeding TDP-43A315T
mice with non-transgenic C57/BL6 mice. Animals were group-
housed under standard housing conditions with a 12 h light–dark
cycle, and food and water ad libitum. All animals expressing the
TDP-43A315T were conﬁrmed via PCR according to the distrib-
utor’s protocol. Non-transgenic littermates not expressing the
TDP-43A315T were used as wild-type controls. All animal proto-
cols andprocedureswere approvedbyMelbourneResearchAnimal
Ethics at The University of Melbourne, Australia. Only male mice
were included in this study and the number of animals per group
is stated in the ﬁgure legends.
BEHAVIORAL TESTING
Locomotor activity was assessed using the rotarod assay (Turner
et al., 2009); rod diameter 35 mm and elevation 200 mm. Mice
were acclimatized to the rotarod by daily training for one week.
Training involved three 5-min training runs per mouse per day.
For each training run themice were returned to the rotarod if they
fell before the end of the 5-min period. Once the mice reached
5 weeks of age they were tested twice weekly. During testing, the
rotarod was set to accelerate from 4 to 40 rpm over 5 min. Latency
to fall was recorded in seconds. On each testing day each mouse
was tested twice and only higher latency to fall score used for
analysis.
Cognitive function was assessed using the Y-maze test as previ-
ously described (Hung et al., 2012) and performed at the age of 10
weeks. The ﬂoor of the maze was covered with sawdust which was
replaced between each training and testing run in order to pre-
vent residual odors that may affect performance. The walls of the
maze were non-transparent and decorated internally so that each
arm was visually unique. For training each mouse was allowed to
explore only two arms of themaze (the novel armwas blockedwith
a non-transparent wall) for 10 min. At the end of training mice
were removed from the maze for a period of 1 h before returning
and being allowed to explore all 3 arms of the maze for 5 min.
For training and testing the mice were placed into the maze at the
same position in the starting arm of the maze. During testing the
number of entries made to each arm of themaze was recorded and
the percentage of entries into the novel third arm was calculated.
TISSUE COLLECTION AND PREPARATION
Male mice (mean age of 12 weeks) were anesthetized by intraperi-
toneal injection of PBS (137 mM NaCl, 8.1 mM Na2HPO4,
2.68 mM KCl, 1.47 mM KH2PO4, pH 7.4) supplemented with
ketamine (20mg/mL) and xylazine (4mg/mL). Animals were then
transcardially perfused with PBS containing 0.25% phosphatase
inhibitor cocktail, 1% protease inhibitor (Roche) and 20 U/mL
heparin. Perfused brain, spinal cord, liver, and quadriceps muscle
were collected, frozen on dry ice and stored at −80◦C until further
processing.
Forwestern blot analysis, enzyme-linked immunosorbent assay
(ELISA) and protein oxidation detection, tissues were mechani-
cally homogenized in 150–200μL homogenizing buffer [PBS con-
taining 1:100protease inhibitor cocktail (Roche), 1:50phosphatase
inhibitor cocktail and 1:20 DNase (Roche)] before ultrasonication
at 2 amp for 10 s. Homogenates were centrifuged at 18,000 g for
3 min at 4◦C and the supernatant (soluble fraction) collected and
the pellet (insoluble fraction) retained. Protein content was deter-
mined by the bicinchoninic acid assay (Thermo Scientiﬁc, USA).
Fractions were stored at −80◦C until further analysis.
WESTERN BLOT ANALYSIS
Soluble tissue fractions were prepared in 4× loading buffer
[250 mM Tris, 20% (v/v) glycerol, 8% (w/v) SDS, 2% (v/v)
β-mercaptoethanol, 0.01% (w/v) bromophenol blue] and heated
for 5 min at 95◦C. Samples containing 10–30 μg protein were
then loaded onto 4–12% NuPAGE Novex Bis–Tris Midi gels
(Life Technologies) electrophoresed at 200 V for 40 min. Pro-
teins were transferred onto PVDF membranes using the iBlot
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gel transfer device (Life Technologies) for 7 min according
to the manufacturer’s instructions. Membranes were blocked
with 4% (w/v) skim milk in PBS containing 0.05% (v/v)
Tween-20 (PBST) followed by incubation with primary antibody
(1:1000) overnight at 4◦C. After washes in PBST, membranes
were incubated with secondary antibody for 1 h at room tem-
perature. Membranes were incubated with Western Lighting
Ultra ECL (Perkin-Elmer) and imaged using the Fujiﬁlm LAS-
3000 Image reader. Blots were then stripped with 1% HCl
for 15 min and reprobed for GAPDH or histone H3 as load-
ing control. The optical density (OD) of bands was quantiﬁed
using the ImageJ software and standardized to loading control
(GAPDH/histone H3). The relative fold change for proteins in
TDP-43A315T mouse tissue is expressed relative towild-typemouse
tissue.
METAL ANALYSIS
Inductively coupled plasma mass spectrometry (ICP-MS) was
used to measure bulk metal concentration in tissue samples as
described elsewhere (Maynard et al., 2002). Brieﬂy, perfused brain
and spinal cord tissue samples were lyophilized then digested in
HNO3 (65% Suprapur, Merck) overnight. Liver and quadriceps
muscles were used as control non-CNS tissue. Tissues were heated
at 90oC before the addition of H2O2 (30%Aristar, BDH). Samples
were left to stand for∼30min, before further heating at 70oC. The
average reduced volumewas determined and samples were further
diluted with 1% HNO3. Measurements were made using an Agi-
lent 7700 series ICP-MS instrument using a Helium Reaction Gas
Cell and 200 ppb of Yttrium (Y89) as an internal control (ICP-MS-
IS-MIX1-1, Accustandard). Results are expressed as micrograms
of metal per gram of wet weight tissue (μg/g).
PROTEIN OXIDATION DETECTION AND MCP-1 ELISA
Oxidative stress and inﬂammation are associated with metal
dyshomeostasis and neurodegeneration (Barnham et al., 2004;
Molina-Holgado et al., 2007). To assess the oxidative and inﬂam-
matory status of the brain and spinal cord of the TDP-43A315T we
measured levels of oxidized proteins and the inﬂammationmarker
monocyte chemoattractant protein 1 (MCP-1). Brain and spinal
cord soluble and insoluble fractions were analyzed for oxidative
modiﬁed proteins via the OxyBlot Protein Oxidation Detection
Kit (Merck Millipore, Australia) according to the manufacturer’s
instructions. The OxyBlot detects the carbonyl groups found on
oxidized proteins. The OD of bands was quantiﬁed using the
ImageJ software and values were standardized to the loading con-
trols GAPDH and histone H3 for soluble and insoluble fractions,
respectively. The relative fold change of oxidized proteins in TDP-
43A315T mice is expressed relative to wild-type. Levels of MCP-1
were measured in brain, spinal cord, liver and quadriceps muscle
using the Mouse CCL2/JE/MCP-1 DuoSet (R&D Systems, USA)
according to the manufacturer’s instructions.
STATISTICAL ANALYSIS
All values are presented as mean ± SEM. All statistical analyses
were performed using Graphpad Prism. Planned comparisons
using two-tailed independent t-tests were used to analyze all data.
Signiﬁcance was set at p < 0.05.
RESULTS
TDP-43A315T MICE EXHIBIT LOCOMOTOR IMPAIRMENT BUT NO
COGNITIVE DEFICIT
Consistent with the original description of the TDP-43A315T mice
(Wegorzewska et al., 2009), the FLAG-tagged TDP-43A315T was
readily detected in the brain and spinal cord relative to the liver
and quadriceps muscles, indicating that the mutant TDP-43 is
mainly expressedwithin the CNS in thismodel (Figure 1A).When
assessed using an antibody that detected both the FLAG-tagged
mutant TDP-43 and the endogenous mouse TDP-43, expression
of TDP-43was∼7-fold higher in the transgenic animals compared
to wild-type controls (Figure 1B).
To investigate whether the TDP-43A315T mouse model reca-
pitulate symptoms of ALS, the rotarod was used to assess loco-
motor activity. Lower scores on the rotarod are indicative of
impaired locomotor function. TDP-43A315T mice consistently
scored lower than wild-type littermates at all time-points exam-
ined (Figure 1C). The poor performance of TDP-43A315T mice
on the rotarod decreased further towards the end of the study
period, dropping sharply at ∼12 weeks of age until end-stage at
14.2 ± 1.3 weeks. Unlike mutant SOD1 mouse models of ALS
(Gurney et al., 1994; Wong et al., 1995) full hind-limb paralysis
was not evident at end-stage in the TDP-43A315T mice. Accord-
ingly, the TDP-43A315T mice maintained locomotor functionality
through to end-stage (Figure 1C).
The Y-maze was used to examine whether the TDP-43A315T
mice exhibited a cognitive deﬁcit reminiscent of FTLD. Cognitive
function was examined in males at 10 weeks of age to ensure
that testing was assessed before the dramatic late stage decline in
locomotor function. The number of entries into the novel arm
of the Y-maze, indicative of short-term memory function, did
not differ signiﬁcantly between the TDP-43A315T mice and their
age-matched wild-type littermates (p > 0.05; Figure 1D).
INCREASED METAL LEVELS IN THE SPINAL CORD OF TDP-43A315T MICE
Bulkmetal analysis was performed using ICP-MS and levels of Na,
Mg,Al, P,K,Ca, Ti,Mn, Fe, Cu, andZnwere quantiﬁed in the brain
and spinal cord of TDP-43A315T and wild-type mice (Figure 2).
Bulk levels of these metals were not signiﬁcantly different in the
brain between genotypes (p> 0.05; Figures 2A–K). However,Mn,
Cu, and Zn were signiﬁcantly increased in the spinal cord of TDP-
43A315Tmice when compared to wild-type controls by 19.8, 16.9,
and 18.8%, respectively (p < 0.05; Figures 2H,J,K). Changes to
Mn, Cu, and Zn observed in the spinal cord tissue appeared to
be restricted to this tissue; as per the brain, these metals were not
altered in the liver or quadriceps muscle (Figures 2H,J,K).
INCREASED OXIDATIVE STRESS IN THE SPINAL CORD OF TDP-43A315T
MICE
TheOxyBlot kit was used to detect the levels of oxidized proteins as
ameasure of oxidative stress in brain and spinal cord fractions. The
level of oxidized proteins in the soluble brain and spinal cord frac-
tions (containing mostly cytosolic proteins) of TDP-43A315T mice
wasnot different fromwild-typemice (Figure 3A). However,when
assessing the insoluble fraction, containingmainlymembrane and
nuclear material, there was a signiﬁcant 2.2-fold increase in the
level of oxidized proteins in the spinal cord of TDP-43A315T mice
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FIGURE 1 |TDP-43A315T mice express mutantTDP-43 in the CNS and
exhibit a locomotor impairment. (A) Representative western blot
showing the absence of mutant FLAG-taggedTDP-43 (FLAG) expression
(Continued)
FIGURE 1 | Continued
in the brain of wild-type (WT) mice and the expression of FLAG-tagged
TDP-43 in the brain (Br), and spinal cord (SC) but not liver (L) and quadriceps
muscle (Q) of transgenic TDP-43A315T (Tg) mice. (B)Western blot analysis
show a signiﬁcant overexpression of total TDP-43 in the brain and spinal
cord of Tg mice (n = 9) compared toWT (n = 9). ***p < 0.001; *p < 0.05.
Blots shown are representative images. OD of bands were standardized to
GAPDH and expressed relative toWT. (C)Tg mice exhibit a locomotor
impairment compared toWT, scoring lower on the rotarod test thanWT
with a further decline in locomotor activity beginning at ∼12 weeks. (D) No
signiﬁcant differences were detected in the number of novel arm entries of
theY-maze test betweenWT andTg mice (p > 0.05).
when compared to wild-type (p < 0.05; Figure 3B). There were
no differences in the insoluble brain fraction between genotypes
(Figure 3B).
INCREASED MARKERS OF INFLAMMATION IN THE BRAIN AND SPINAL
CORD OF TDP-43A315T MICE
Monocyte chemoattractant protein-1 is involved in microglia-
mediated inﬂammatory processes in theCNS and canbe used as an
indicator of increased inﬂammation (Deshmane et al., 2009). Lev-
els of MCP-1, as detected by ELISA, were signiﬁcantly increased
in the brain and spinal cord of TDP-43A315T mice by 1.7- and
1.4-fold, respectively (p < 0.05; Figure 4).
DISCUSSION
Metal dyshomeostasis is implicated in a number of neurodegen-
erative diseases (Soﬁc et al., 1988; Connor et al., 1992; Lovell et al.,
1998), but whether metals play a role in the degeneration of
neurons in TDP-43 associated forms of diseases such as FTLD-
U and ALS is unknown. In this study, the TDP-43A315T mouse
model of FTLD/ALS TDP-43 proteinopathy was used to exam-
ine potential metal changes in the CNS due to expression of a
pathogenic form of mutant TDP-43. Consistent with previous
studies (Wegorzewska et al., 2009), FLAG-tagged mutant TDP-43
wasmainly expressed within the CNS of TDP-43A315T mice result-
ing in the overexpression of TDP-43 in the brain and spinal cord.
These animals exhibited a locomotor impairment reminiscent of
ALS. The TDP-43A315Tmice performed poorly on the rotarod test
and demonstrated a progressive loss of locomotor activity towards
end-stage. This observation is consistent with those reported by
Esmaeili and colleagues (2013). Full hind-limb paralysis was not
evident prior to the premature death of the TDP-43A315T mice.
Bulk metal analysis of the spinal cord revealed a signiﬁcant
increase in the levels of manganese, Cu and Zn due to expres-
sion of mutant TDP-43 in the TDP-43A315Tmice (Figure 2). These
changes appear speciﬁc to the spinal cord tissue as manganese,
copper and zinc were not altered in the brain, liver, or quadri-
ceps muscle (Figure 2). Rotarod analysis of the TDP-43A315T
mice revealed a clear deﬁcit relative to wild-type mice, but the
Y-maze assessment of the TDP-43A315T mice indicated expression
of the mutant TDP-43 did not affect the cognitive function of
these animals (Figure 1D). This apparent demarcation between
symptoms of neuronal decline in the spinal cord compared to
neuronal decline in the brain is despite the higher levels of the
mutant TDP-43 expression in the brain compared to spinal cord
(Figure 1B). Thus, the effects of mutant TDP-43 expression on
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FIGURE 2 | Increased metal content in the spinal cord ofTDP-43A315T
mice. ICP-MS analysis of bulk metal content in the brain (Br), spinal cord (SC),
liver (L) and quadriceps muscle (Q) of TDP-43A315T mice (Tg), and wild-type
litter mates (WT). (A–K) Planned comparisons revealed no signiﬁcant
differences in bulk levels of Na, Mg, Al, P, K, Ca, Ti, Mn, Fe, Cu, and Zn in the
brain between genotyptes (n = 16 per genotype); however, (H) Mn, (J) Cu,
and (K) Zn were signiﬁcantly increased in the spinal cord of Tg mice
compared toWT controls (n = 7 per genotype). **p < 0.01; *p < 0.5.
FIGURE 3 | Increased oxidative stress in the spinal cord of
TDP-43A315Tmice. (A)The level of oxidized proteins as determined by
OxyBlot is unchanged in the soluble fraction (containing cytosolic proteins) of
the brain (Br) and spinal cord (SC) of TDP-43A315T mice (Tg) compared to
wild-type littermates (WT). (B) Levels of oxidized proteins were signiﬁcantly
increased in spinal cord insoluble fraction (containing membrane and nuclear
material) of Tg compared toWT; *p < 0.05; n = 8 per genotype. No changes
were detected in brain insoluble factions.
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FIGURE 4 | Increased markers of inflammation inTDP-43A315T mice.
MCP-1 ELISA show a signiﬁcant increase in MCP-1 content in the brain (Br)
and spinal cord (SC) of TDP-43A315T mice (Tg) compared to wild-type (WT).
***p < 0.001; *p < 0.05. n = 9 per genotype for brain; n = 7 per genotype
for spinal cord.
metals in the spinal cord, but not the brain, may have contributed
to the predominantly locomotor phenotype of the TDP-43A315T
mice.
The mechanisms by which mutant TDP-43 could contribute
to elevated levels of these metals in the spinal cord remain to be
fully elucidated, and it is not yet clear whether the altered metal
content of the spinal cord represents a cause or consequence of
neuronal dysfunction. The data generated for levels of oxidized
proteins (Figure 3), however, are in part consistent with the altered
metal content representing a causative event. Despite no change
to levels of oxidized proteins in the soluble fraction, the abun-
dance of oxidized proteins in the insoluble fraction was elevated
in the spinal cords of TDP-43A315T mice. Oxidative damage is
evident in the spinal cords of ALS cases (Niebroj-Dobosz et al.,
2004) as well as mutant SOD1 mouse models of the disease (Soon
et al., 2011), and altered metal homeostasis has been associated
with this oxidative damage. Most notably, the pro-oxidant toxic
gain-of-function ascribed to mutant SOD1 in SOD1-associated
cases of ALS is proposed to be the result of altered metallation
of SOD1 (Beckman et al., 2001). The normal anti-oxidant activity
of SOD1 requires equimolar binding of Zn and Cu, but disrup-
tions to this metal stoichiometry, including disruptions caused
by ALS-associated SOD1 mutations (Crow et al., 1997; Roberts
et al., 2007) confer toxic pro-oxidant activity to the SOD1 (Estevez
et al., 1999). Signiﬁcantly, altered metallation of wild-type SOD1
also confers a pro-oxidant toxic gain-of-function (Estevez et al.,
1999). It is possible therefore, that the mutant-TDP-43 induced
disruption of metal homeostasis detected in the spinal cords
of the TDP-43A315T mice contributed to a neurotoxic oxidative
mechanism already proposed as a signiﬁcant pathogenic event
in ALS.
In contrast to oxidative damage, the data generated for levels
of the inﬂammatory marker MCP-1 are less clear with respect
to inﬂammation possibly contributing to the mutant TDP-43-
induced phenotype of the TDP-43A315T mice. Levels of MCP-1
were elevated in the spinal cords of TDP-43A315T mice, and they
were also elevated in the brain (Figure 4). Given the mice did
not display an overt cognitive phenotype indicative of neuronal
dysfunction in the brain, these data may suggest the inﬂamma-
tion present in the brains of the TDP-43A315T mice represents
a relatively non-speciﬁc response to the over-expression of an
exogenous protein. Alternatively, these data may represent a spe-
ciﬁc consequence of mutant TDP-43 expression, a possibility
consistent with evidence for increased inﬂammation in ALS and
FTLD (Galimberti et al., 2008; Letiembre et al., 2009; Papadim-
itriou et al., 2010). As discussed below, the absence of an overt
cognitive phenotype in the TDP-43A315T mice may be due to the
premature death of these animals preventing the opportunity for
the manifestation of neuronal dysfunction in the brain.
The data presented in this study indicate increased metal levels
in the spinal cords of the TDP-43A315T mice may have contributed
to their locomotor impairment, while the lack of cognitive impair-
ment may be due to the absence of metal dyshomeostasis in the
brain. However, this study only performed bulk metal analysis
whereby whole tissue homogenates were analyzed for total metal
levels. Region speciﬁc changes to metals or the redistribution
of metals in the brain may therefore have been undetected by
this methodology. Alternate analytical techniques such as laser-
ablation ICP-MS which allows for spatial resolution of metal
concentrations within tissues (Hare et al., 2012) or liquid chro-
matography ICP-MS which allows resolution of metalloproteins
prior to metal quantitation (Lothian et al., 2013) may therefore
be required before excluding the possibility that expression of
mutant TDP-43 caused relatively subtle changes to metals within
the brains of the TDP-43A315T mice. In addition, it must be noted
that the TDP-43A315T mouse model has recently been reported
to die prematurely from gastrointestinal complications before the
development of full ALS- and FTLD-like symptoms (Guo et al.,
2012; Esmaeili and colleagues, 2013). Although we did not study
these gastrointestinal complications, we did ﬁnd that the TDP-
43A315T mice died suddenly before the presence of full hind-limb
paralysis. This raises the possibility that if these mice had not
died from their gastrointestinal complications theymay have gone
on to exhibit symptoms of cognitive decline. Thus, the non-CNS
related premature death of the TDP-43A315T mice may have been
the only factor that limited the detection of potential alterations
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to brain metal homeostasis and/or cognitive impairment, espe-
cially if FTLD-like symptoms develop much later than ALS-like
symptoms.
Overall, this preliminary study is the ﬁrst to report alteredmetal
content in the spinal cord of the TDP-43A315Tmouse model of
FTLD and ALS. The increase in metal content is associated with
increased oxidative stress and inﬂammation in this tissue. The
mechanismbywhichmutant TDP-43 can altermetal levels and the
effect of these changes on the oxidative and inﬂammatory status of
the CNS remains to be elucidated, and an analysis of these changes
to spinal cordmetal levels is needed to address their temporal rela-
tionship with the progressive phenotype of the TDP-43A315Tmice.
Nonetheless, the data from this study provide evidence to support
the role of metal dyshomeostasis in neurodegenerative diseases,
including TDP-43 proteinopathies.
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